We are live on ! Find out more
VCYT icon

Veracyte

125 hedge funds and large institutions have $465M invested in Veracyte in 2018 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 40 increasing their positions, 44 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

127% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 11

37% more capital invested

Capital invested by funds: $340M → $465M (+$125M)

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

13% more funds holding

Funds holding: 111125 (+14)

0.99% more ownership

Funds ownership: 90.18%91.17% (+0.99%)

9% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 44

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $254K

Holders
125
Holders Change
+14
Holders Change %
+12.61%
% of All Funds
2.77%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
25
Increased
40
Reduced
44
Closed
11
Calls
Puts
$254K
Net Calls
-$254K
Net Calls Change
-$1.03M

VCYT Hedge Fund Activity: Q4 2018 in Review

125 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q4 2018, worth a combined $465M — up 37% from $340M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new VCYT positions and 11 closed out — a net gain of 14 holders — while 40 added to existing stakes and 44 trimmed.

The largest buyer was Assenagon Asset Management, opening a new position worth an estimated $14.4M. The largest seller was Eventide Asset Management, cutting an estimated $14.2M.

  • 125 institutional investors held Veracyte (VCYT) as of Q4 2018, up from 111 in Q3 2018.
  • Funds reported $465M of Veracyte stock for Q4 2018, up 37% quarter-over-quarter.
  • 25 funds opened new Veracyte positions in Q4 2018 and 11 closed out, a net change of +14 holders.
  • The largest Veracyte buyer in Q4 2018 was Assenagon Asset Management, an estimated $14.4M added.
  • The largest Veracyte seller in Q4 2018 was Eventide Asset Management, an estimated $14.2M sold.

Based on aggregated 13F filings for Q4 2018.